Evidence map›Paper›PMID 23260110›Full record

ArticleVirology2013

Interleukin 2-inducible T cell kinase (ITK) facilitates efficient egress of HIV-1 by coordinating Gag distribution and actin organization.

Gillian M Schiralli Lester, Hisashi Akiyama, Erica Evans, Juswinder Singh, Suryaram Gummuluru, Andrew J Henderson

Abstract read
In one paragraph

Article in Virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. CD4AIDS research and human retroviruses · 2018
    Review
  3. Article
  4. Article
  5. Article
  6. Nucleocapsid Protein: A Desirable Target for Future Therapies Against HIV-1.Current topics in microbiology and immunology · 2015
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Gillian M Schiralli LesterDepartment of Medicine, Section of Infectious Diseases, Boston University School of Medicine, Boston, MA 02118, United States.
Hisashi Akiyama
Erica Evans
Juswinder Singh
Suryaram Gummuluru
Andrew J Henderson
Boston University · US

Funding

Mechanism of cell-associated HIV-1 transmissionR01AI064099 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GUMMULURU, SURYARAM · 2005 to 2020
$5.9M
Regulation of HIV by T-Cell Signal TransductionR01AI062467 · NIAID · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI HENDERSON, ANDREW J · 2005 to 2009
$1.2M
Regulation of HIV by T-Cell Signal TransductionR21AI062467 · NIAID · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI HENDERSON, ANDREW J · 2004 to 2004
$321k
NIAID NIH HHS AI062467NIAID NIH HHS R01 AI062467NIAID NIH HHS R01 AI064099NIAID NIH HHS R21 AI062467
6 · The paper itself

Abstract

Interleukin 2-inducible T cell kinase (ITK) influences T cell signaling by coordinating actin polymerization and polarization as well as recruitment of kinases and adapter proteins. ITK regulates multiple steps of HIV-1 replication, including virion assembly and release. Fluorescent microscopy was used to examine the functional interactions between ITK and HIV-1 Gag during viral particle release. ITK and Gag colocalized at the plasma membrane and were concentrated at sites of F-actin accumulation and membrane lipid rafts in HIV-1 infected T cells. There was polarized staining of ITK, Gag, and actin towards sites of T cell conjugates. Small molecule inhibitors of ITK disrupted F-actin capping, perturbed Gag-ITK colocalization, inhibited virus like particle release, and reduced HIV replication in primary human CD4+ T cells. These data provide insight as to how ITK influences HIV-1 replication and suggest that targeting host factors that regulate HIV-1 egress provides an innovative strategy for controlling HIV infection.

Indexed as

ActinsCD4-Positive T-LymphocytesCell Line, TumorCell Membranegag Gene Products, Human Immunodeficiency VirusHIV-1HIV InfectionsHumansInterleukin-2Jurkat CellsMembrane MicrodomainsProtein-Tyrosine KinasesSignal TransductionVirus AssemblyVirus ReleaseVirus ReplicationActinsemt protein-tyrosine kinasegag Gene Products, Human Immunodeficiency VirusInterleukin-2Protein-Tyrosine Kinases

Identifiers

PMID23260110
PMCPMC3598624
OpenAlexW2023491903

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.